This article discusses features that predict local recurrence and distant metastasis in rectal cancer, and how to use MRI to guide treatment decisions.
Robert Glynne-Jones, MBBS, FRCP, FRCR
Advertisement
Articles by Robert Glynne-Jones, MBBS, FRCP, FRCR
Advertisement
Latest Updated Articles
- Pelvic MRI for Guiding Treatment Decisions in Rectal Cancer
August 15th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
2
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
3
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
4
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
5